Medtronic: Finding the Bottom
The market cannot keep punishing this medical-device powerhouse, whose share price is down 21% in 2006.
- (opens in new tab)
- (opens in new tab)
- (opens in new tab)
- Newsletter sign up Newsletter
Medtronic embodies everyone's frustration with the poor performance of so-called megacap stocks. Good earnings, a high return on equity, innovative new products, lots and lots of cash on the balance sheet -- you name it, Medtronic is a sound company. But merely being sound doesn't cut it in a market that remains hostile to the likes of big growth companies such as Microsoft, Wal-Mart and, yes, Medtronic.
Medtronic, by far the largest manufacturer of medical and orthopedic devices by stock-market value, has been a major disappointment to investors. At $45, the stock (symbol MDT (opens in new tab)) has essentially done nothing over the past five years, although the company's profits grew by 150% over that period.
This week's earnings report, for the quarter that ended July 28, contains enough hopeful news that Medtronic shares look like a good bet to make up for some of this lost time. For one thing, Medtronic backtracked from its tradition of publicly forecasting 15% sales and earnings growth for the next several years. That gives it some wiggle room if it takes longer than advertised to realize substantial returns on its research into new products for back and spine trouble, diabetes, and neurological disorders -- the areas that can compensate for slowing growth in cardiac devices.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
It may sound silly, but if a company predicts 15% growth and makes 13%, investors may punish the stock. Don't promise such growth, and it becomes easier to make the number or to find a way to surprise the market to the upside. Analysts and investors actually sometimes go for this stuff. "A much-needed cut" in guidance, says Cowen Co. Prudential Securities suggests that Medtronic officials really do aim to achieve 15% growth but are promoting the smaller number to analysts and investors.
Medtronic's stock could have suffered some more on August 23, but its quarterly earnings of 55 cents a share beat the average analyst estimate of 54 cents. So the stock barely budged. Three weeks ago, however, when the company warned that its defibrillator business had some problems, the stock plunged from $51 to $44. At $45, it's priced at 19 times profit estimates for the fiscal year ending next April -- about half the price-earnings ratio this stock commanded during its glory days of the 1990s. That's a reasonable price, especially when you factor in all the demographic appeal of a company that profits when baby boomers need expensive surgery and cardiac care.
Skeptics counter that, like Wal-Mart, Medtronic's best days are behind it. But if the megacaps ever get a little more respect, Medtronic deserves to be released from five years in investor purgatory.
-
-
When Is the Next Fed Meeting?
Investors, savers and consumers can expect another interest rate hike at the next Fed meeting.
By Dan Burrows • Published
-
Need an Estate Planning Checkup? Now Is the Perfect Time
An appointment with your estate planning attorney can address any holes that have developed and ensure everything is in place.
By Jack R. Hales Jr., J.D. • Published
-
Stock Market Today: Stocks End the Week on a High Note
Intel stock plunged after a big earnings miss, but encouraging inflation and consumer sentiment data created tailwinds for the broad market.
By Karee Venema • Published
-
Kiplinger's Weekly Earnings Calendar (Jan. 30-Feb. 1)
stocks Check out our earnings calendar for the upcoming week, as well as our previews of the more noteworthy reports.
By Karee Venema • Published
-
Stock Market Today: Stocks Climb After Tesla Earnings, GDP
The electric vehicle maker reported record profit and revenue for the fourth quarter.
By Karee Venema • Published
-
Stock Market Today: Microsoft Earnings Weigh on Stocks
While Microsoft reported top- and bottom-line beats in its fiscal Q2, shares declined on disappointing guidance.
By Karee Venema • Published
-
The S&P 500 Dividend Aristocrats Are Getting 3 New Members
Dividend Aristocrats The index of stocks that have upped their dividends for at least 25 straight years is about to get bigger.
By Dan Burrows • Last updated
-
Stock Market Today: Dow Gains After Busy Day of Blue-Chip Earnings
Travelers and 3M were two Dow components that reported earnings today.
By Karee Venema • Published
-
Stock Market Today: Stocks Climb After Spotify Job Cuts
Spotify became the latest company to announce layoffs, while Salesforce climbed on activist investor news.
By Karee Venema • Published
-
Stock Market Today: Netflix, Alphabet Lead Rally in Tech Stocks
Netflix reported much higher-than-expected subscriber growth, while Wall Street cheered Alphabet's layoff announcement.
By Karee Venema • Published